These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1306 related items for PubMed ID: 8780630

  • 1. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.
    Dillman RO, Herndon J, Seagren SL, Eaton WL, Green MR.
    J Natl Cancer Inst; 1996 Sep 04; 88(17):1210-5. PubMed ID: 8780630
    [Abstract] [Full Text] [Related]

  • 2. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P, Herndon J, Langer M, Kohman LJ, Elias AD, Kass FC, Eaton WL, Seagren SL, Green MR, Sugarbaker DJ.
    Cancer; 1996 Jun 01; 77(11):2393-9. PubMed ID: 8635112
    [Abstract] [Full Text] [Related]

  • 3. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer.
    Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC, Carey RW, Frei EF, Green MR.
    N Engl J Med; 1990 Oct 04; 323(14):940-5. PubMed ID: 2169587
    [Abstract] [Full Text] [Related]

  • 4. Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06.
    Komaki R, Scott C, Lee JS, Urtasun RC, Byhardt RW, Emami B, Andras EJ, Asbell SO, Rotman M, Cox JD.
    Am J Clin Oncol; 1997 Oct 04; 20(5):435-40. PubMed ID: 9345325
    [Abstract] [Full Text] [Related]

  • 5. Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy Oncology Group.
    Johnstone DW, Byhardt RW, Ettinger D, Scott CB.
    Int J Radiat Oncol Biol Phys; 2002 Oct 01; 54(2):365-9. PubMed ID: 12243809
    [Abstract] [Full Text] [Related]

  • 6. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group.
    Komaki R, Scott CB, Sause WT, Johnson DH, Taylor SG, Lee JS, Emami B, Byhardt RW, Curran WJ, Dar AR, Cox JD.
    Int J Radiat Oncol Biol Phys; 1997 Oct 01; 39(3):537-44. PubMed ID: 9336129
    [Abstract] [Full Text] [Related]

  • 7. Alternating radiotherapy and chemotherapy for inoperable Stage III non-small-cell lung cancer: long-term results of two Phase II GOTHA trials. Groupe d'Oncologie Thoracique Alpine.
    Mirimanoff RO, Moro D, Bolla M, Michel G, Brambilla C, Mermillod B, Miralbell R, Alberto P.
    Int J Radiat Oncol Biol Phys; 1998 Oct 01; 42(3):487-94. PubMed ID: 9806505
    [Abstract] [Full Text] [Related]

  • 8. Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04.
    Komaki R, Scott C, Ettinger D, Lee JS, Fossella FV, Curran W, Evans RF, Rubin P, Byhardt RW.
    Int J Radiat Oncol Biol Phys; 1997 Apr 01; 38(1):149-55. PubMed ID: 9212017
    [Abstract] [Full Text] [Related]

  • 9. Role of radiotherapy in combined modality treatment of locally advanced non-small-cell lung cancer.
    Kubota K, Furuse K, Kawahara M, Kodama N, Yamamoto M, Ogawara M, Negoro S, Masuda N, Takada M, Matsui K.
    J Clin Oncol; 1994 Aug 01; 12(8):1547-52. PubMed ID: 8040666
    [Abstract] [Full Text] [Related]

  • 10. Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: long-term follow-up of RTOG 92-04.
    Komaki R, Seiferheld W, Ettinger D, Lee JS, Movsas B, Sause W.
    Int J Radiat Oncol Biol Phys; 2002 Jul 01; 53(3):548-57. PubMed ID: 12062596
    [Abstract] [Full Text] [Related]

  • 11. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.
    Curran WJ, Paulus R, Langer CJ, Komaki R, Lee JS, Hauser S, Movsas B, Wasserman T, Rosenthal SA, Gore E, Machtay M, Sause W, Cox JD.
    J Natl Cancer Inst; 2011 Oct 05; 103(19):1452-60. PubMed ID: 21903745
    [Abstract] [Full Text] [Related]

  • 12. Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small-cell lung cancer.
    Crinò L, Latini P, Meacci M, Corgna E, Maranzano E, Darwish S, Minotti V, Santucci A, Tonato M.
    Ann Oncol; 1993 Dec 05; 4(10):847-51. PubMed ID: 8117604
    [Abstract] [Full Text] [Related]

  • 13. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study.
    Strauss GM, Herndon JE, Sherman DD, Mathisen DJ, Carey RW, Choi NC, Rege VB, Modeas C, Green MR.
    J Clin Oncol; 1992 Aug 05; 10(8):1237-44. PubMed ID: 1321893
    [Abstract] [Full Text] [Related]

  • 14. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study.
    Zatloukal P, Petruzelka L, Zemanova M, Havel L, Janku F, Judas L, Kubik A, Krepela E, Fiala P, Pecen L.
    Lung Cancer; 2004 Oct 05; 46(1):87-98. PubMed ID: 15364136
    [Abstract] [Full Text] [Related]

  • 15. Phase II study of three-dimensional conformal radiotherapy and concurrent mitomycin-C, vinblastine, and cisplatin chemotherapy for Stage III locally advanced, unresectable, non-small-cell lung cancer.
    Lee SW, Choi EK, Lee JS, Lee SD, Suh C, Kim SW, Kim WS, Ahn SD, Yi BY, Kim JH, Noh YJ, Kim SS, Koh Y, Kim DS, Kim WD.
    Int J Radiat Oncol Biol Phys; 2003 Jul 15; 56(4):996-1004. PubMed ID: 12829135
    [Abstract] [Full Text] [Related]

  • 16. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
    Semrau S, Bier A, Thierbach U, Virchow C, Ketterer P, Fietkau R.
    Strahlenther Onkol; 2003 Dec 15; 179(12):823-31. PubMed ID: 14652671
    [Abstract] [Full Text] [Related]

  • 17. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung.
    Byhardt RW, Scott C, Sause WT, Emami B, Komaki R, Fisher B, Lee JS, Lawton C.
    Int J Radiat Oncol Biol Phys; 1998 Oct 01; 42(3):469-78. PubMed ID: 9806503
    [Abstract] [Full Text] [Related]

  • 18. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.
    Rusu P, Ciuleanu TE, Cernea D, Pelau D, Gaal V, Cebotaru C, Guttman T, Todor N, Ghilezan N.
    J BUON; 2007 Oct 01; 12(1):33-9. PubMed ID: 17436399
    [Abstract] [Full Text] [Related]

  • 19. Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group.
    Clamon G, Herndon J, Cooper R, Chang AY, Rosenman J, Green MR.
    J Clin Oncol; 1999 Jan 01; 17(1):4-11. PubMed ID: 10458211
    [Abstract] [Full Text] [Related]

  • 20. A phase III randomized trial of combined chemoradiotherapy versus radiotherapy alone in locally advanced non-small-cell lung cancer.
    Kim TY, Yang SH, Lee SH, Park YS, Im YH, Kang WK, Ha SH, Park CI, Heo DS, Bang YJ, Kim NK.
    Am J Clin Oncol; 2002 Jun 01; 25(3):238-43. PubMed ID: 12040280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 66.